RA
NVO

Riversedge Advisors’s Novo Nordisk NVO Stock Holding History

Riversedge Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,703
Closed -$257K – 132
2025
Q1 		$257K Sell
3,703
-65
-2% -$5.37K 0.06% 98
2024
Q4 		$324K Buy
3,768
+245
+7% +$26.5K 0.07% 74
2024
Q3 		$419K Sell
3,523
-33
-0.9% -$4.4K 0.1% 59
2024
Q2 		$508K Buy
3,556
+383
+12% +$50.8K 0.12% 52
2024
Q1 		$407K Buy
3,173
+324
+11% +$38.6K 0.1% 55
2023
Q4 		$295K Buy
+2,849
New +$282K 0.08% 63

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Riversedge Advisors's NVO Position: Q2 2025 in Review

Riversedge Advisors sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 3,703 shares — an estimated $257K sold.

Riversedge Advisors first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $508K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Riversedge Advisors reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Riversedge Advisors sold 3,703 Novo Nordisk shares in Q2 2025, an estimated $257K.
  • Riversedge Advisors first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • Riversedge Advisors's Novo Nordisk position peaked at $508K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Riversedge Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.